Table 2.
Difference in percentage of people screened within 40 days after the invitation for breast cancer screening program (2020 versus 2019, Flanders)
| January, 1 (week 1)– December,31 (week 52) | January, 1 (week1)-March 21 (week11) | July, 5 (week 27) – December, 31 (week 52) | July, 5 (week 27) -November, 28 (week 47) | |
|---|---|---|---|---|
| (entire year) | (before first COVID-19 shutdown) | (after the restart of the program) | (first 20 weeks after restart of the program) | |
| % (95% CI) | % (95% CI) | % (95% CI) | % (95% CI) | |
| All invitation | -1.0 (-1.3; -0.8) | -1.4 (-1.9; -1.0) | -1.0 (-1.3; -0.7) | -1.6 (-2.0; -1.3) |
| Stratified by age | ||||
| 50–54 | -0.5 (-1.0; -0.1) | -2.9 (-3.7; -2.1) | 0.4 (-0.1; 1.0) | 0.0 (-0.6; 0.6) |
| 55–59 | -1.7 (-2.2; -1.2) | -4.0 (-4.9; -3.1) | -0.8 (-1.4; -0.2) | -1.7 (-2.4; -1.0) |
| 60–64 | -1.0 (-1.5; -0.6) | -0.3 (-1.1; 0.6) | -1.9 (-2.5; -1.3) | -3.2 (-3.8; -2.5) |
| 65–69 | -1.5 (-2.0; -1.0) | -0.5(-1.4; 0.4) | -2.1 (-2.8; -1.4) | -2.3 (-3.0; -1.6) |
| Stratified by screening history | ||||
| Type 1 | -3.0 (-3.3; -2.7) | 0.1 (-0.4; 0.6) | -4.0 (-4.4; -3.7) | -4.4(-4.8; -4.0) |
| Type 2 | -1.1 (-1.8; -0.4) | -2.8 (-3.9; -1.6) | 0.6 (-0.3; 1.5) | -0.3 (-1.2; 0.7) |
| Type 3 | -1.8 (-2.4; -1.2) | -1.1 (-2.2; -0.1) | -2.2 (-3.0; -1.4) | -2.5(-3.3; -1.6) |
| Type 4 | 0.1 (-0.2; 0.3) | -0.9 (-1.4; -0.4) | 0.7 (0.3; 1.0) | 0.3 (-0.1; 0.7) |